Poly Medicure
Poly Medicure, also known as Poly Medicure Limited, is a leading player in the medical device industry, headquartered in India. Established in 1998, the company has made significant strides in the healthcare sector, particularly in the fields of infusion therapy, vascular access, and wound care. With a strong operational presence across Asia, Europe, and the Americas, Poly Medicure has positioned itself as a trusted provider of innovative medical solutions. The company’s core offerings include a diverse range of products such as intravenous catheters, blood transfusion sets, and surgical sutures, all designed with a focus on safety and efficacy. Poly Medicure is recognised for its commitment to quality and has achieved several certifications, enhancing its reputation in the global market. With a robust portfolio and a dedication to advancing healthcare, Poly Medicure continues to set benchmarks in the medical device industry.
DitchCarbon Score
How does Poly Medicure's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Poly Medicure's score of 21 is higher than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Poly Medicure's reported carbon emissions
In 2023, Poly Medicure reported total carbon emissions of approximately 33,230,620 kg CO2e from Scope 2 and about 3,114,940 kg CO2e from Scope 1, resulting in a combined total of approximately 36,345,560 kg CO2e. This represents a significant reduction from 2022, where the company emitted about 25,400,000 kg CO2e from Scope 1 and 21,000,000 kg CO2e from Scope 2, totalling approximately 46,400,000 kg CO2e. In 2024, emissions further decreased, with Scope 1 emissions at about 2,319,850 kg CO2e and Scope 2 emissions at approximately 33,962,280 kg CO2e, leading to a total of around 36,282,130 kg CO2e. Despite these reductions, Poly Medicure has not publicly disclosed specific reduction targets or climate pledges. The company continues to focus on improving its emissions intensity, achieving approximately 2.7e-09 kg CO2e per rupee of turnover in 2024, down from 3.1e-09 kg CO2e in 2023. Overall, Poly Medicure is making strides in reducing its carbon footprint, although further commitments and targets would enhance its climate strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Get Started| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 25,400,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 21,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Poly Medicure is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
